These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 975716)

  • 1. Renal failure, hemodialysis, and nafcillin kinetics.
    Rudnick M; Morrison G; Walker B; Singer I
    Clin Pharmacol Ther; 1976 Oct; 20(4):413-23. PubMed ID: 975716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nafcillin in patients with renal failure.
    Diaz CR; Kane JG; Parker RH; Pelsor FR
    Antimicrob Agents Chemother; 1977 Jul; 12(1):98-101. PubMed ID: 883823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sotalol kinetics in renal insufficiency.
    Blair AD; Burgess ED; Maxwell BM; Cutler RE
    Clin Pharmacol Ther; 1981 Apr; 29(4):457-63. PubMed ID: 7471612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
    Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K
    Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and nondialyzability of mexiletine in renal failure.
    Wang T; Wuellner D; Woosley RL; Stone WJ
    Clin Pharmacol Ther; 1985 Jun; 37(6):649-53. PubMed ID: 4006364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetics of aminosidine in renal patients with different degrees of renal failure.
    Novarini A; Montanari A; Bruschi G; Rossi E; Borghetti A; Migone L
    Clin Nephrol; 1975 Jul; 4(1):23-4. PubMed ID: 1157346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefamandole in patients with renal failure.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysis.
    Stec GP; Atkinson AJ; Nevin MJ; Thenot JP; Ruo TI; Gibson TP; Ivanovich P; del Greco F
    Clin Pharmacol Ther; 1979 Nov; 26(5):618-28. PubMed ID: 91468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M; Kuroda K
    Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous azlocillin kinetics in patients on long-term hemodialysis.
    Aletta JM; Francke EF; Neu HC
    Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir kinetics in end-stage renal disease.
    Laskin OL; Longstreth JA; Whelton A; Rocco L; Lietman PS; Krasny HC; Keeney RE
    Clin Pharmacol Ther; 1982 May; 31(5):594-601. PubMed ID: 7075109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose kinetics and dosage of mecillinam in renal failure and haemodialysis.
    Schapira A
    Clin Pharmacokinet; 1984; 9(4):364-70. PubMed ID: 6088153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial.
    Lee PT; Chou KJ; Liu CP; Mar GY; Chen CL; Hsu CY; Fang HC; Chung HM
    J Am Coll Cardiol; 2007 Sep; 50(11):1015-20. PubMed ID: 17825709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol kinetics in renal failure.
    McAinsh J; Holmes BF; Smith S; Hood D; Warren D
    Clin Pharmacol Ther; 1980 Sep; 28(3):302-9. PubMed ID: 7408390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.